Finance

Lists
SION:NASDAQ
Sionna Therapeutics Inc
$45.70
+3.72%
(+1.64) 1D
Jul 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SION...
Open
$44.31
High
$46.40
Low
$43.41
Mkt. cap
2.06B
Avg. vol.
544.31K
Volume
654.94K
52-wk high
$51.56
52-wk low
$16.38
EPS
-$1.92
Shares outstanding
45.15M
No. of employees
59
Open
$44.31
High
$46.40
Low
$43.41
Mkt. cap
2.06B
Avg. vol.
544.31K
Volume
654.94K
52-wk high
$51.56
52-wk low
$16.38
EPS
-$1.92
Shares outstanding
45.15M
No. of employees
59
News stories
From sources across the web
About Sionna Therapeutics Inc
CEO-
Employees59
Founded2019
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitesionnatx.com
Analyst ratings
Based on 9 analysts giving stock ratings to SION in the past 3 months
Buy
Buy
7
Hold
1
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SION in the last 3 months.
Highest
Current $45.70
$63.00 (+37.86%)
Average
$51.43 (+12.54%)
Lowest
$23.00 (-49.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ritu Baral
TD Cowen
Buy
Maintained
$49.41
+8.1%
07/17/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
$63.00
+37.9%
06/25/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$50.00
+9.4%
06/23/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
$60.00
+31.3%
06/22/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$55.00
+20.4%
05/25/2026
Ilya Zubkov
Freedom Capital Markets
Hold
Downgraded
-
-
05/20/2026
Laura Chico
Wedbush
Buy
Maintained
$53.00
+16%
05/18/2026
Kambiz Yazdi
BTIG
Buy
Reiterated
$58.00
+26.9%
05/12/2026
Brian Abrahams
RBC Capital
Sell
Maintained
$23.00
-49.7%
05/12/2026
Jonathan Wolleben
Citizens JMP
Buy
Initiated
$63.00
+37.9%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.38M
16.04M
15.17M
18.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.52M
7.76M
8.44M
10.64M
Operating expense
21.91M
23.80M
23.61M
29.60M
Total operating expenses
21.91M
23.80M
23.61M
29.60M
Operating income
-21.91M
-23.80M
-23.61M
-29.60M
Other non operating income
171.00K
71.00K
-
-
EBT including unusual items
-18.07M
-20.28M
-20.44M
-26.78M
EBT excluding unusual items
-18.07M
-20.28M
-20.44M
-26.78M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-18.07M
-20.28M
-20.44M
-26.78M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.46
-0.46
-0.60
Interest and investment income
3.67M
3.46M
3.17M
2.82M
Interest expense
-
-
-
-
Net interest expenses
3.67M
3.46M
3.17M
2.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.76M
-23.62M
-23.46M
-29.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer